Take Solutions

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE142I01023
  • NSEID: TAKE
  • BSEID: 532890
INR
30.69
-0.17 (-0.55%)
BSENSE

Jun 02

BSE+NSE Vol: 2.99 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

2.99 lacs (13.33%) Volume

Shareholding (Mar 2026)

FII

0.29%

Held by 3 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

0.00%

how big is Take Solutions?

06-Jun-2025

As of Jun 06, Take Solutions Ltd has a market capitalization of 129.00 Cr, categorizing it as a Micro Cap company, with total assets of 85.90 Cr and shareholder's funds at -8.87 Cr as of Mar'24.

Market Cap: Take Solutions Ltd has a market capitalization of 129.00 Cr, categorizing it as a Micro Cap company as of Jun 06.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters, which includes Mar'25, Dec'24, Sep'24, and Jun'24, is 0.00 Cr. The sum of Net Profit for the same quarters is 37.47 Cr. This data is presented on a Consolidated basis.<BR><BR>Balance Sheet Snapshot: This is Consolidated data for the latest annual period ending in Mar'24. Shareholder's Funds are reported at -8.87 Cr, while Total Assets amount to 85.90 Cr.

View full answer

Who are in the management team of Take Solutions?

06-Jun-2025

As of March 2023, the management team of Take Solutions includes H R Srinivasan (Non-Executive Director), Shobana N S (Executive Director), P Srinivasan (Company Secretary & Compliance Officer), and several Independent Directors: Chella Gowrishankar, Chandrasekaran Nagarajan, Kiran Sharma, and Ramesh Gopal. Each member plays a key role in the company's governance and operations.

As of March 2023, the management team of Take Solutions includes the following individuals:<BR><BR>1. H R Srinivasan - Non Executive Director<BR>2. Shobana N S - Executive Director<BR>3. P Srinivasan - Company Secretary & Compliance Officer<BR>4. CHELLA GOWRISHANKAR - Director<BR>5. CHANDRASEKARAN NAGARAJAN - Independent Director<BR>6. Rangasami Seshadri - Independent Director<BR>7. Kiran Sharma - Independent Director<BR>8. RAMESH GOPAL - Independent Director<BR><BR>Each member holds a specific designation contributing to the governance and operations of the company.

View full answer

What does Take Solutions do?

06-Jun-2025

Take Solutions Ltd is a micro-cap company in the Healthcare Services sector, providing services in Life Sciences, Software, and IT. As of March 2025, it reported a net profit of -5 Cr and has a market cap of Rs 129 Cr.

Overview: <BR>Take Solutions Ltd is a micro-cap company in the Healthcare Services industry that delivers domain-intensive services and solutions in Life Sciences, Software, and Information Technology.<BR><BR>History: <BR>Take Solutions Limited was incorporated on December 20, 2000. The latest quarterly results reported are for March 2025, showing a net profit of -5 Cr.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: -5 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: Rs 129 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 129.00 <BR>Industry P/E: 29 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: -0.17 <BR>Return on Equity: 3.60% <BR>Price-to-Book: 6.26 <BR><BR>Contact Details: <BR>Address: No 27 Tank Bund Road, Nungambakkam Chennai Tamil Nadu : 600034 <BR>Tel: 91-044-24617358/24617359 <BR>Email: secretarial@takesolutions.com <BR>Website: http://www.takesolutions.com

View full answer

Has Take Solutions declared dividend?

06-Jun-2025

Take Solutions Ltd has declared a 40% dividend, amounting to 0.4 per share, but the dividend yield is 0%. The company has experienced significant losses over various periods, with total returns ranging from -49.6% to -86.45%.

Take Solutions Ltd has declared a 40% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 40%<BR>- Amount per share: 0.4<BR>- Ex-date: 01 Aug 19<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -49.6%, the dividend return was 0%, resulting in a total return of -49.6%.<BR><BR>Over the past year, the price return was -55.81%, the dividend return was 0%, leading to a total return of -55.81%.<BR><BR>For the 2-year period, the price return was -50.72%, the dividend return was 0%, culminating in a total return of -50.72%.<BR><BR>In the 3-year span, the price return was -62.62%, the dividend return was 0%, which resulted in a total return of -62.62%.<BR><BR>Over the last 4 years, the price return was -86.45%, the dividend return was 0%, leading to a total return of -86.45%.<BR><BR>Finally, in the 5-year period, the price return was -85.18%, the dividend return was 0%, resulting in a total return of -85.18%.<BR><BR>Overall, while Take Solutions Ltd has declared a dividend, the company has not provided any dividend yield, and the total returns across all periods indicate significant losses, suggesting a challenging financial performance.

View full answer

Who are the peers of the Take Solutions?

03-Jun-2025

Take Solutions' peers include Syngene Intl., Dr Lal Pathlabs, and Royal, among others. While Royal shows excellent growth and the highest 1-year return at 102.17%, Take Solutions has the lowest return at -57.48% and a below-average capital structure.

Peers: The peers of Take Solutions are Syngene Intl., Dr Lal Pathlabs, Poly Medicure, Indegene, Vijaya Diagnost., Royal, Hemant Surgical, Choksi Laborator, Jeevan Scienti., and Aspira Pathlab.<BR><BR>Quality Snapshot: Excellent management risk is observed at Dr Lal Pathlabs, while Good management risk is found at Syngene Intl., Poly Medicure, Indegene, and Hemant Surgical, and the rest have Below Average management risk. Growth ratings show that Excellent growth is seen at Royal, while Average growth is noted at Indegene and Poly Medicure, and the rest have Below Average growth. Capital Structure is Excellent for Syngene Intl., Dr Lal Pathlabs, Poly Medicure, Indegene, Vijaya Diagnost., and Royal, while Below Average capital structure is found at Take Solutions, Choksi Laborator, and the rest.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Royal at 102.17%, while Take Solutions has the lowest at -57.48%. This indicates that Take Solutions' performance is significantly worse compared to its peers. Additionally, the six-month return is negative for Take Solutions, Syngene Intl., Poly Medicure, Vijaya Diagnost., Hemant Surgical, and Jeevan Scienti.

View full answer

Is Take Solutions overvalued or undervalued?

09-Jun-2025

As of May 31, 2024, Take Solutions is considered risky and overvalued due to a high PE ratio of 128.70, negative EV to EBIT of -16.66, and a troubling ROCE of -43.98%, especially when compared to peers like TCS and Infosys, while also underperforming the Sensex with a year-to-date return of -45.88%.

As of 31 May 2024, the valuation grade for Take Solutions has moved from attractive to risky, indicating a significant shift in its financial outlook. The company is currently deemed overvalued, particularly when considering its high PE ratio of 128.70 and a negative EV to EBIT of -16.66. Additionally, the return on capital employed (ROCE) stands at a concerning -43.98%, which further underscores the company's financial struggles.<BR><BR>When compared to peers, Take Solutions' valuation metrics are starkly unfavorable. For instance, TCS, which is rated attractive, has a PE ratio of 25.23, while Infosys, rated fair, has a PE of 24.32. The PEG ratio for Take Solutions is 1.26, which, while not excessively high, is still indicative of overvaluation relative to its peers. The company's recent stock performance has also lagged behind the Sensex, with a year-to-date return of -45.88% compared to the Sensex's 5.59%, reinforcing the perception of overvaluation in the current market context.

View full answer

What is the technical trend for Take Solutions?

09-Jun-2025

As of May 14, 2025, Take Solutions shows a mildly bearish trend overall, with mixed signals from MACD and bearish moving averages, despite a mildly bullish weekly MACD.

As of 14 May 2025, the technical trend for Take Solutions has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD remains bearish. The moving averages on a daily basis are mildly bearish, and the Bollinger Bands show a bearish trend in both weekly and monthly time frames. The KST is mildly bullish weekly but bearish monthly, and Dow Theory reflects a mildly bearish position on the weekly chart with no trend on the monthly. Overall, the current technical stance is mildly bearish, driven primarily by the mixed signals from MACD and the bearish moving averages.

View full answer

When is the next results date for Take Solutions?

03-Jul-2025

Take Solutions will announce its results on July 7, 2025.

Take Solutions will declare its results on 07 July 2025.

View full answer

Who are the top shareholders of the Take Solutions?

17-Jul-2025

The top shareholders of Take Solutions are Take Solutions Pte Limited, which holds 52.9% of the shares, and individual investors who collectively own 40.45%. There are no mutual funds or foreign institutional investors currently involved.

The top shareholders of Take Solutions include the promoters, with Take Solutions Pte Limited holding the largest share at 52.9%. Additionally, individual investors collectively hold 40.45% of the company's shares. There are no mutual funds or foreign institutional investors (FIIs) currently holding shares in the company.

View full answer

How has been the historical performance of Take Solutions?

28-Oct-2025

Take Solutions has experienced a significant decline in financial performance, with net sales dropping from 2,212.90 crore in March 2020 to 0.00 crore in March 2025, although it reported a net profit of 37.47 crore in March 2025 after years of losses. Total assets also fell sharply from 2,464.45 crore to 36.48 crore during the same period.

Answer:<BR>The historical performance of Take Solutions shows a significant decline in net sales and profitability over the years, culminating in a net profit of 37.47 crore in March 2025 after several years of losses.<BR><BR>Breakdown:<BR>Take Solutions experienced a drastic drop in net sales from 2,212.90 crore in March 2020 to 0.00 crore in March 2025. The total operating income followed a similar trend, decreasing from 2,212.90 crore in March 2020 to 0.00 crore in March 2025. Operating profit (PBDIT) also fell sharply, moving from a profit of 195.29 crore in March 2020 to a loss of 7.47 crore in March 2025. The company reported a profit before tax of 0.74 crore in March 2025, a recovery from the previous years of losses, while profit after tax also showed a positive shift to 0.74 crore. The total assets decreased significantly from 2,464.45 crore in March 2020 to 36.48 crore in March 2025, reflecting a severe contraction in the company's financial position. Despite these challenges, the company managed to achieve a net cash inflow of 2.00 crore in March 2025, contrasting with the negative cash flows seen in prior years.

View full answer

Are Take Solutions Ltd latest results good or bad?

21-May-2026

Take Solutions Ltd's latest results show a return to revenue with net sales of ₹54.19 crores and a net profit of ₹4.36 crores, but the company faces significant concerns due to negative operating margins, reliance on non-operating income, and the complete exit of promoters, indicating an unfavorable overall assessment.

Take Solutions Ltd's latest results for Q4 FY26 present a mixed picture that leans towards concern. On one hand, the company reported net sales of ₹54.19 crores, marking its first revenue after several quarters of zero sales, which is a positive sign of some operational activity resuming. Additionally, the consolidated net profit of ₹4.36 crores reflects a significant increase of 292.79% quarter-over-quarter, which might seem encouraging at first glance.<BR><BR>However, a deeper analysis reveals troubling underlying issues. The operating margin, excluding other income, was deeply negative at -1.51%, indicating that the core business remains unprofitable despite the revenue generation. The reported profit was heavily reliant on other income, which accounted for 118.81% of the profit before tax, raising serious questions about the sustainability and quality of the earnings.<BR><BR>Moreover, the complete exit of promoters from the company signals a lack of confidence in its recovery prospects. The company's financial health has deteriorated significantly over the years, with shareholder funds collapsing from ₹1,124.69 crores in March 2021 to just ₹20.53 crores in March 2025. <BR><BR>In summary, while the return to revenue generation is a positive development, the ongoing operational losses, reliance on non-operating income for profitability, and the complete promoter exit suggest that the results are more indicative of a speculative situation rather than a solid recovery. Therefore, the overall assessment of Take Solutions Ltd's latest results leans towards being unfavorable.

View full answer

Should I buy, sell or hold Take Solutions Ltd?

22-May-2026

Why is Take Solutions Ltd falling/rising?

01-Jun-2026

As of 01-Jun, Take Solutions Ltd's stock price is at 30.86, down 0.36%. The stock has underperformed significantly over the past month and year-to-date, despite a notable increase over the past year, indicating a troubling trend.

As of 01-Jun, Take Solutions Ltd's stock price is currently at 30.86, reflecting a decrease of 0.11 or 0.36%. The stock has been underperforming, having lost 0.42% over the last two days, and it has consistently fallen during this period. Additionally, the stock has underperformed its sector by 2.35% today, indicating a lack of momentum compared to its peers in the IT - Software sector, which has gained 2.04%.<BR><BR>In terms of longer-term performance, the stock has seen a significant decline of 27.35% over the past month, while the benchmark Sensex has only decreased by 3.44%. Year-to-date, the stock is down 22.38%, compared to a 12.85% decline in the Sensex. Despite a remarkable increase of 248.31% over the past year, the recent trends suggest a troubling trajectory.<BR><BR>The moving averages indicate that the stock is currently above its 5-day and 200-day moving averages but below its 20-day, 50-day, and 100-day moving averages, which may suggest a weakening trend. Although there has been a rise in investor participation, with a 19.79% increase in delivery volume, this has not translated into positive price movement.<BR><BR>Overall, the combination of recent price declines, underperformance against the sector, and negative short-term trends contribute to the current falling price of Take Solutions Ltd's stock.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -3.65
  • The company has reported losses. Due to this company has reported negative ROCE
2

Flat results in Mar 26

3

Risky - Negative EBITDA

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Healthcare Services

stock-summary
Market cap

INR 454 Cr (Micro Cap)

stock-summary
P/E

107.00

stock-summary
Industry P/E

21

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.01

stock-summary
Return on Equity

13.74%

stock-summary
Price to Book

14.73

Revenue and Profits:
Net Sales:
54 Cr
(Quarterly Results - Mar 2026)
Net Profit:
4 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-23.68%
0%
-23.68%
6 Months
-6.4%
0%
-6.4%
1 Year
253.16%
0%
253.16%
2 Years
52.01%
0%
52.01%
3 Years
69.93%
0%
69.93%
4 Years
29.49%
0%
29.49%
5 Years
-53.54%
0%
-53.54%

Latest dividend: 0.4 per share ex-dividend date: Aug-01-2019

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Announcements stock-summary

Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday May 30 2026.

30-May-2026 | Source : BSE

Resignation and Appointment of Secretarial Auditor of the Company.

Announcement under Regulation 30 (LODR)-Newspaper Publication

22-May-2026 | Source : BSE

Newspaper Advertisement of the Audited Financial Results for the quarter and financial year ended March 31 2026

Announcement under Regulation 30 (LODR)-Press Release / Media Release

20-May-2026 | Source : BSE

Press Release - Audited Financial Results for the quarter and financial year ended 31 March 2026.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Take Solutions Ltd has declared 40% dividend, ex-date: 01 Aug 19

stock-summary
SPLITS

Take Solutions Ltd has announced 1:10 stock split, ex-date: 18 Sep 08

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
-41.25%
EBIT Growth (5y)
14.75%
EBIT to Interest (avg)
-3.65
Debt to EBITDA (avg)
2.58
Net Debt to Equity (avg)
-0.01
Sales to Capital Employed (avg)
1.31
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.29%
ROCE (avg)
4.48%
ROE (avg)
3.35%

Valuation key factors

Factor
Value
P/E Ratio
107
Industry P/E
21
Price to Book Value
14.73
EV to EBIT
-237.70
EV to EBITDA
-237.70
EV to Capital Employed
14.86
EV to Sales
8.42
PEG Ratio
0.36
Dividend Yield
NA
ROCE (Latest)
-6.25%
ROE (Latest)
13.74%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 3 FIIs (0.29%)

Promoter with highest holding

Take Solutions Pte Limited (0.0%)

Highest Public shareholder

Akarshika Traders (8.38%)

Individual Investors Holdings

31.59%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 189.34% vs 95.59% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "54.19",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.82",
          "val2": "-1.14",
          "chgp": "28.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.24",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-5.18",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4.36",
          "val2": "-4.88",
          "chgp": "189.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1.51%",
          "val2": "0.00%",
          "chgp": "-1.51%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 0.00% vs -100.00% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 200.94% vs 22.42% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.75",
          "val2": "-1.64",
          "chgp": "54.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.35",
          "val2": "0.99",
          "chgp": "-64.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "6.59",
          "val2": "-2.68",
          "chgp": "345.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "5.38",
          "val2": "-5.33",
          "chgp": "200.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 0.00% vs -100.00% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -84.68% vs 570.03% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.10",
          "val2": "-4.53",
          "chgp": "75.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.35",
          "val2": "1.72",
          "chgp": "-79.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "6.59",
          "val2": "40.10",
          "chgp": "-83.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "6.49",
          "val2": "42.35",
          "chgp": "-84.68%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 0.00% vs -100.00% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is -71.04% vs 131.32% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "54.19",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.91",
          "val2": "-7.47",
          "chgp": "74.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.35",
          "val2": "1.96",
          "chgp": "-82.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "6.59",
          "val2": "36.73",
          "chgp": "-82.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "10.85",
          "val2": "37.47",
          "chgp": "-71.04%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-3.52%",
          "val2": "0.00%",
          "chgp": "-3.52%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoYstock-summary

Mar'26
Mar'25
Change(%)
Net Sales
54.19
0.00
Operating Profit (PBDIT) excl Other Income
-0.82
-1.14
28.07%
Interest
0.00
0.24
-100.00%
Exceptional Items
0.00
-5.18
100.00%
Consolidate Net Profit
4.36
-4.88
189.34%
Operating Profit Margin (Excl OI)
-1.51%
0.00%
-1.51%
Values in Rs Cr.
Net Sales

YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 189.34% vs 95.59% in Mar 2025

Half Yearly Results Snapshot (Consolidated) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.75
-1.64
54.27%
Interest
0.35
0.99
-64.65%
Exceptional Items
6.59
-2.68
345.90%
Consolidate Net Profit
5.38
-5.33
200.94%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 0.00% vs -100.00% in Sep 2024

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2025 is 200.94% vs 22.42% in Sep 2024

Nine Monthly Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-1.10
-4.53
75.72%
Interest
0.35
1.72
-79.65%
Exceptional Items
6.59
40.10
-83.57%
Consolidate Net Profit
6.49
42.35
-84.68%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is 0.00% vs -100.00% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2025 is -84.68% vs 570.03% in Dec 2024

Annual Results Snapshot (Consolidated) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
54.19
0.00
Operating Profit (PBDIT) excl Other Income
-1.91
-7.47
74.43%
Interest
0.35
1.96
-82.14%
Exceptional Items
6.59
36.73
-82.06%
Consolidate Net Profit
10.85
37.47
-71.04%
Operating Profit Margin (Excl OI)
-3.52%
0.00%
-3.52%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is 0.00% vs -100.00% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2026 is -71.04% vs 131.32% in Mar 2025

stock-summaryCompany CV
About Take Solutions Ltd stock-summary
stock-summary
Take Solutions Ltd
Micro Cap
Healthcare Services
Take Solutions Limited was incorporated on December 20, 2000. The Company has been promoted by a team of domain experts in the supply chain management sector of the software industry. TAKE Solutions delivers domain-intensive services and solutions in Life Sciences, Software and Information Technology. In the fast-growing Life Sciences space, the Company offers clients a unique combination of full-service Clinical, Regulatory and Safety services backed by unique technology expertise.
Company Coordinates stock-summary
Company Details
No 27 Tank Bund Road, Nungambakkam Chennai Tamil Nadu : 600034
stock-summary
Tel: 91-044-24617358/24617359
stock-summary
secretarial@takesolutions.com
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai